{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:38:29Z","timestamp":1789519109942,"version":"build-2803163510"},"reference-count":77,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016177","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:39:07Z","timestamp":1770125947000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metformin for asthma exacerbations"],"prefix":"10.1002","volume":"2026","author":[{"given":"Nurul Syafiqah","family":"Othman","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"},{"name":"Faculty of Pharmacy; International Islamic University Malaysia; Kuantan Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-3902","authenticated-orcid":false,"given":"Amy HY","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Harrison","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede A","family":"Beyene","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wright-St Clair","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataly","family":"Martini","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Gong","sequence":"additional","affiliation":[{"name":"School of Pharmacy; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"10.1002\/14651858.CD016177-BIB0001|cit1","unstructured":"World Health Organization Asthma fact sheets; May 2024 Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/asthma"},{"key":"10.1002\/14651858.CD016177-BIB0002|cit2","unstructured":"Global strategy for asthma management and prevention; May 2024 Available at https:\/\/ginasthma.org\/2024-report\/ 2024"},{"issue":"1","key":"10.1002\/14651858.CD016177-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12931-023-02475-6","article-title":"Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"24","author":"Wang","year":"2023","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD016177-BIB0004|cit4","unstructured":"Centers for Disease Control and Prevention (CDC) Controlling asthma; January 2024 Available at https:\/\/www.cdc.gov\/asthma\/control\/index.html"},{"issue":"17","key":"10.1002\/14651858.CD016177-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/diagnostics14171869","article-title":"Asthma and hyperglycemia: exploring the interconnected pathways","volume":"14","author":"Narendra","year":"2024","journal-title":"Diagnostics"},{"key":"10.1002\/14651858.CD016177-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.rmed.2017.03.003","article-title":"Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults","volume":"125","author":"Rastogi","year":"2017","journal-title":"Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD016177-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1442-200x.2000.01278.x","article-title":"Parental concern towards the use of inhaled therapy in children with chronic asthma","volume":"42","author":"Chan","year":"2000","journal-title":"Pediatrics International"},{"issue":"12","key":"10.1002\/14651858.CD016177-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.bcp.2012.09.025","article-title":"Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase","volume":"84","author":"Park","year":"2012","journal-title":"Biochemical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD016177-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"e76786","DOI":"10.1371\/journal.pone.0076786","article-title":"Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice","volume":"8","author":"Calixto","year":"2013","journal-title":"PLOS One"},{"issue":"7","key":"10.1002\/14651858.CD016177-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/resp.12869","article-title":"Asthma and diabetes: does treatment with metformin improve asthma?","volume":"21","author":"Forno","year":"2016","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD016177-BIB0011|cit11","unstructured":"Lee B Man KK Wong E Tan T Sheikh A Bloom CI Effect of antidiabetic medication on asthma attacks: a UK self-controlled case series and population-based cohort study Available at https:\/\/www.researchgate.net\/publication\/381815493_Effect_of_Antidiabetic_Medication_on_Asthma_Attacks_A_UK_Self-Controlled_Case_Series_and_Population-Based_Cohort_Study 10.2139\/ssrn.4878312"},{"issue":"7","key":"10.1002\/14651858.CD016177-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/resp.12818","article-title":"Metformin use and asthma outcomes among patients with concurrent asthma and diabetes","volume":"21","author":"Li","year":"2016","journal-title":"Respirology"},{"issue":"12","key":"10.1002\/14651858.CD016177-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1513\/annalsats.201812-897oc","article-title":"Association of metformin initiation and risk of asthma exacerbation. A claims-based cohort study","volume":"16","author":"Wu","year":"2019","journal-title":"Annals of the American Thoracic Society"},{"issue":"11","key":"10.1002\/14651858.CD016177-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1016\/j.jaip.2021.07.007","article-title":"Metformin use and risk of asthma exacerbation among asthma patients with glycemic dysfunction","volume":"9","author":"Wu","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"4","key":"10.1002\/14651858.CD016177-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"L545","DOI":"10.1152\/ajplung.00232.2020","article-title":"Insulin acutely increases agonist-induced airway smooth muscle contraction in humans and rats","volume":"320","author":"Proskocil","year":"2021","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1002\/14651858.CD016177-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2015.02.003","article-title":"Antidiabetic agents: potential anti-inflammatory activity beyond glucose control","volume":"41","author":"Scheen","year":"2015","journal-title":"Diabetes & Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD016177-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.jaip.2024.05.002","article-title":"Association of novel antihyperglycemic drugs versus metformin with a decrease in asthma exacerbations","volume":"12","author":"Kimura","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology. In Practice"},{"key":"10.1002\/14651858.CD016177-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"107365","DOI":"10.1016\/j.rmed.2023.107365","article-title":"Asthma exacerbations in New Zealand 2010-2019: a national population-based study","volume":"217","author":"Chan","year":"2023","journal-title":"Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD016177-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jaci.2021.10.007","article-title":"Socioeconomic disparities in asthma health care utilization, exacerbations, and mortality: a systematic review and meta-analysis","volume":"149","author":"Redmond","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD016177-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/cen.14193","article-title":"Racial and ethnic differences in the metabolic response of polycystic ovary syndrome","volume":"93","author":"Ezeh","year":"2020","journal-title":"Clinical Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD016177-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.rbmo.2020.12.006","article-title":"Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review","volume":"42","author":"Sendur","year":"2021","journal-title":"Reproductive Biomedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD016177-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"9705604","DOI":"10.1155\/2020\/9705604","article-title":"Association of metformin use with asthma exacerbation in patients with concurrent asthma and diabetes: a systematic review and meta-analysis of observational studies","volume":"2020","author":"Wen","year":"2020","journal-title":"Canadian Respiratory Journal"},{"key":"10.1002\/14651858.CD016177-BIB0023|cit23","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"71","key":"10.1002\/14651858.CD016177-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD016177-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18773\/austprescr.2023.005","article-title":"Limitations of randomised controlled trials as evidence of drug safety","volume":"46","author":"Thynne","year":"2023","journal-title":"Australian Prescriber"},{"issue":"2","key":"10.1002\/14651858.CD016177-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jpurol.2024.11.021","article-title":"Randomized controlled trials - the what, when, how and why","volume":"21","author":"Braga","year":"2025","journal-title":"Journal of Pediatric Urology"},{"key":"10.1002\/14651858.CD016177-BIB0027|cit27","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016177-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jclinepi.2022.08.015","article-title":"Inclusion of nonrandomized studies of interventions in systematic reviews of intervention effectiveness: an update guidance from the Agency for Health Care Research and Quality Effective Health Care program","volume":"152","author":"Saldanha","year":"2022","journal-title":"Agency for Healthcare Research and Quality (US)"},{"issue":"4","key":"10.1002\/14651858.CD016177-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/aje\/kwac037","article-title":"Can cross-sectional studies contribute to causal inference? It depends","volume":"192","author":"Savitz","year":"2023","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD016177-BIB0031|cit31","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0032|cit32","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1 (updated March 2025). Cochrane, 2025 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-021-01658-3","article-title":"Metformin use and respiratory outcomes in asthma-COPD overlap","volume":"22","author":"Wu","year":"2021","journal-title":"Respiratory Research"},{"issue":"1","key":"10.1002\/14651858.CD016177-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD016177-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD016177-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD016177-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the asthma quality of life questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"key":"10.1002\/14651858.CD016177-BIB0038|cit38","unstructured":"Corcoran C Jacobs TF Metformin StatPearls [Internet]. Available From: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518983\/ StatPearls Publishing"},{"issue":"2","key":"10.1002\/14651858.CD016177-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/17512433.2024.2306223","article-title":"Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022","volume":"17","author":"Du","year":"2024","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD016177-BIB0040|cit40","unstructured":"Peryer G Golder S Junqueira D Vohra S Loke YK Chapter 19: Adverse effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD016177-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"585\u201393","DOI":"10.4239\/wjd.v14.i5.585","article-title":"Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes","volume":"14","author":"Sayedali","year":"2023","journal-title":"World Journal of Diabetes"},{"issue":"3","key":"10.1002\/14651858.CD016177-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaci.2011.12.983","article-title":"Asthma outcomes: exacerbations","volume":"129","author":"Fuhlbrigge","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD016177-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.anai.2021.03.022","article-title":"A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA)","volume":"127","author":"Tejwani","year":"2021","journal-title":"Annals of Allergy, Asthma, Immunology"},{"key":"10.1002\/14651858.CD016177-BIB0044|cit44","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD016177-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.jaip.2024.05.034","article-title":"Risk factors for acute asthma exacerbations in adults with mild asthma","volume":"12","author":"Chen","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD016177-BIB0046|cit46","unstructured":"EndNote The EndNote Team Clarivate 2013"},{"key":"10.1002\/14651858.CD016177-BIB0047|cit47","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD016177-BIB0048|cit48","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Chapter 9: Summarizing study characteristics and preparing for synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD016177-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1900900","DOI":"10.1183\/13993003.00900-2019","article-title":"European Respiratory Society\/ European Academy of Allergy and Clinical Immunology (ERS\/EAACI) statement on severe exacerbations in asthma in adults: facts, priorities and key research questions","volume":"54","author":"Bourdin","year":"2019","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD016177-BIB0050|cit50","unstructured":"Review Manager (RevMan) The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD016177-BIB0051|cit51","unstructured":"Sterne JA Hern\u00e1n MA McAleenan A Reeves BC Higgins JP Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0052|cit52","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016177-BIB0054|cit54","unstructured":"Higgins JP Li T Sterne J Revised Cochrane risk of bias tool for randomized trials (RoB 2) additional considerations for crossover trials Available from https:\/\/drive.google.com\/file\/d\/11LFgCuDpWk5-BvBNbHtNzbJv5-qVpTWb\/view"},{"key":"10.1002\/14651858.CD016177-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"e076754","DOI":"10.1136\/bmj-2023-076754","article-title":"ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis","volume":"383","author":"Page","year":"2023","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016177-BIB0056|cit56","unstructured":"Page MJ Higgins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016177-BIB0058|cit58","unstructured":"Eldridge S Campbell MK Campbell MJ Drahota AK Giraudeau B Reeves BC Revised Cochrane risk of bias tool for randomized trials (RoB 2): additional considerations for cluster-randomized trials (RoB 2 CRT) Available at https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool\/rob-2-for-cluster-randomized-trials"},{"key":"10.1002\/14651858.CD016177-BIB0059|cit59","unstructured":"Boutron I Page MJ Higgins JPT Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD016177-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"e12047","DOI":"10.1002\/cesm.12047","article-title":"Standardized mean differences in meta-analysis: a tutorial","volume":"2","author":"Gallardo-Gomez","year":"2024","journal-title":"Cochrane Evidence Synthesis and Methods"},{"key":"10.1002\/14651858.CD016177-BIB0061|cit61","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0062|cit62","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0063|cit63","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD016177-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"e12033","DOI":"10.1002\/cesm.12033","article-title":"Multiarm studies and how to handle them in a meta-analysis: a tutorial","volume":"1","author":"Axon","year":"2023","journal-title":"Cochrane Evidence Synthesis and Methods"},{"key":"10.1002\/14651858.CD016177-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"111244","DOI":"10.1016\/j.jclinepi.2023.111244","article-title":"Variation observed in consensus judgements between pairs of reviewers when assessing the risk of bias due to missing evidence in a sample of published meta-analyses of nutrition research","volume":"166","author":"Kanukula","year":"2023","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7109","key":"10.1002\/14651858.CD016177-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016177-BIB0067|cit67","unstructured":"Introduction to new random-effects methods in RevMan; October 2024 Available at https:\/\/www.cochrane.org\/events\/introduction-new-random-effects-methods-revman"},{"key":"10.1002\/14651858.CD016177-BIB0068|cit68","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016177-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"16890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD016177-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4081\/mrm.2021.780","article-title":"Impact of asthma severity as risk factor to future exacerbations in patients admitted for asthma exacerbation","volume":"16","author":"Nakwan","year":"2021","journal-title":"Multidisciplinary Respiratory Medicine"},{"key":"10.1002\/14651858.CD016177-BIB0071|cit71","unstructured":"Metformin; 2018 Available at https:\/\/www.medsafe.govt.nz\/profs\/datasheet\/m\/metformintab.pdf"},{"key":"10.1002\/14651858.CD016177-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"117955142110305","DOI":"10.1177\/11795514211030513","article-title":"Real-world clinical experience on the usage of high-dose metformin (1500-2500 mg\/day) in type 2 diabetes management","volume":"14","author":"Das","year":"2021","journal-title":"Clinical Medicine Insights: Endocrinology and Diabetes"},{"issue":"3","key":"10.1002\/14651858.CD016177-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s13300-021-01017-x","article-title":"Effects of increasing metformin dose vs adding\/switching to dipeptidyl peptidase-4 inhibitors on glycemic control in patients with type 2 diabetes","volume":"12","author":"Nagai","year":"2021","journal-title":"Diabetes Therapy"},{"key":"10.1002\/14651858.CD016177-BIB0074|cit74","unstructured":"Ryan R Santesso N Hill S Preparing summary of findings (SoF) tables Cochrane Consumers and Communication Group. Available at http:\/\/cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD016177-BIB0075|cit75","volume-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews (Internet)","author":"Berkman","year":"2013"},{"key":"10.1002\/14651858.CD016177-BIB0076|cit76","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD016177-BIB0077|cit77","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2025"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:39:10Z","timestamp":1770125950000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016177"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016177","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}